|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
US8398983B2
(en)
|
2005-06-27 |
2013-03-19 |
Glaxosmithkline Biologicals, S.A. |
Immunogenic composition
|
|
NZ598367A
(en)
*
|
2005-09-01 |
2013-10-25 |
Novartis Vaccines & Diagnostic |
Multiple vaccination including serogroup C meningococcus
|
|
GB0522765D0
(en)
*
|
2005-11-08 |
2005-12-14 |
Chiron Srl |
Combination vaccine manufacture
|
|
PL1973564T3
(pl)
|
2005-12-22 |
2017-04-28 |
Glaxosmithkline Biologicals S.A. |
Szczepionki zawierające koniugaty polisacharydu otoczkowego streptococcus pneumoniae
|
|
GB0607088D0
(en)
*
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
US10828361B2
(en)
|
2006-03-22 |
2020-11-10 |
Glaxosmithkline Biologicals Sa |
Regimens for immunisation with meningococcal conjugates
|
|
PL2004225T3
(pl)
|
2006-03-22 |
2012-09-28 |
Novartis Ag |
Schematy immunizacji koniugatami meningokokowymi
|
|
US8945582B2
(en)
*
|
2006-09-07 |
2015-02-03 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
BRPI0810778A2
(pt)
*
|
2007-05-02 |
2011-09-13 |
Glaxosmithkline Biolog Sa |
kit, vacina combinada, e, métodos de diminuição da interferência de vizinhança de crm sobre um antìgeno sensìvel em um esquema de imunização primária de uma vacina, e de diminuição da interferência de vizinhança sobre um antìgeno sensìvel, e, uso de conjugados de sacarìdeo
|
|
CA2688268A1
(en)
*
|
2007-06-04 |
2008-12-11 |
Novartis Ag |
Formulation of meningitis vaccines
|
|
SI2167121T1
(sl)
*
|
2007-06-26 |
2015-12-31 |
Glaxosmithkline Biologicals S.A. |
Cepivo, ki obsega kapsularne polisaharidne konjugate Streptococcusa pneumoniae
|
|
PE20100366A1
(es)
|
2008-10-24 |
2010-05-21 |
Panacea Biotec Ltd |
Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion
|
|
GB0822634D0
(en)
*
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Meningitis vaccines
|
|
GB0822633D0
(en)
*
|
2008-12-11 |
2009-01-21 |
Novartis Ag |
Formulation
|
|
AU2010243285B2
(en)
*
|
2009-04-30 |
2013-06-06 |
Coley Pharmaceutical Group, Inc. |
Pneumococcal vaccine and uses thereof
|
|
EP2430040A1
(en)
*
|
2009-05-11 |
2012-03-21 |
Novartis AG |
Antigen purification process for pertactin antigen
|
|
PT2575870T
(pt)
*
|
2010-06-04 |
2017-02-10 |
Wyeth Llc |
Formulações de vacinas
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
KR101594228B1
(ko)
|
2010-08-23 |
2016-02-15 |
와이어쓰 엘엘씨 |
네이세리아 메닌기티디스 ｒＬＰ２０８６ 항원의 안정한 제제
|
|
NZ607224A
(en)
|
2010-09-10 |
2014-11-28 |
Wyeth Llc |
Non-lipidated variants of neisseria meningitidis orf2086 antigens
|
|
RU2013120302A
(ru)
|
2010-10-01 |
2014-11-20 |
Модерна Терапьютикс, Инк. |
Сконструированные нуклеиновые кислоты и способы их применения
|
|
EP2691101A2
(en)
|
2011-03-31 |
2014-02-05 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
CN103648489A
(zh)
|
2011-05-11 |
2014-03-19 |
儿童医疗中心有限公司 |
多抗原提呈免疫原性组合物及其方法和用途
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
RU2648950C2
(ru)
|
2011-10-03 |
2018-04-02 |
Модерна Терапьютикс, Инк. |
Модифицированные нуклеозиды, нуклеотиды и нуклеиновые кислоты и их применение
|
|
GB2495341B
(en)
*
|
2011-11-11 |
2013-09-18 |
Novartis Ag |
Fermentation methods and their products
|
|
CN102526717A
(zh)
*
|
2011-11-25 |
2012-07-04 |
成都康华生物制品有限公司 |
一种吸附无细胞百白破联合疫苗的制备方法
|
|
CN104114572A
(zh)
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
|
DK2809349T3
(da)
*
|
2012-01-30 |
2019-02-18 |
Serum Institute Of India Pvt Ltd |
Immunogen sammensætning
|
|
US20150110802A1
(en)
*
|
2012-02-29 |
2015-04-23 |
Medlmmune, Llc |
Antibody production methods
|
|
MX359256B
(es)
|
2012-03-09 |
2018-09-19 |
Pfizer |
Composiciones de neisseria meningitidis y metodos de las mismas.
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
CN102600086A
(zh)
*
|
2012-04-01 |
2012-07-25 |
成都欧林生物科技股份有限公司 |
冻干b型流感嗜血杆菌结合疫苗的制备方法
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
AU2013243948A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US20140193451A1
(en)
*
|
2012-10-17 |
2014-07-10 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
|
WO2014081507A1
(en)
|
2012-11-26 |
2014-05-30 |
Moderna Therapeutics, Inc. |
Terminally modified rna
|
|
JP6494527B2
(ja)
|
2013-02-07 |
2019-04-03 |
ザ チルドレンズ メディカル センター コーポレーション |
肺炎球菌のコロニー形成および／または疾患からの保護を提供するタンパク質抗原
|
|
US9802987B2
(en)
|
2013-03-08 |
2017-10-31 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
EP2971010B1
(en)
|
2013-03-14 |
2020-06-10 |
ModernaTX, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
US20160194625A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
RU2662968C2
(ru)
|
2013-09-08 |
2018-07-31 |
Пфайзер Инк. |
Иммуногенная композиция против neisseria meningitidis (варианты)
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
JP2016538829A
(ja)
|
2013-10-03 |
2016-12-15 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
低密度リポタンパク質受容体をコードするポリヌクレオチド
|
|
EP3169693B1
(en)
|
2014-07-16 |
2022-03-09 |
ModernaTX, Inc. |
Chimeric polynucleotides
|
|
WO2016014846A1
(en)
|
2014-07-23 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
CN104383531A
(zh)
*
|
2014-11-18 |
2015-03-04 |
北京智飞绿竹生物制药有限公司 |
预防儿童脑膜炎的联合疫苗及其制备方法
|
|
AU2016221318B2
(en)
|
2015-02-19 |
2020-06-25 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
JP7084683B2
(ja)
*
|
2015-02-23 |
2022-06-15 |
東京応化工業株式会社 |
液体の精製方法、薬液又は洗浄液の製造方法、フィルターメディア、及び、フィルターデバイス
|
|
CN104958759B
(zh)
*
|
2015-06-24 |
2018-04-27 |
康希诺生物股份公司 |
多价脑膜炎球菌制剂盒、疫苗制剂及其制备方法
|
|
WO2017041083A1
(en)
*
|
2015-09-04 |
2017-03-09 |
Inventprise, Llc |
Vlp stabilized vaccine compositions
|
|
PH12018500305B1
(en)
|
2015-09-10 |
2023-03-15 |
Inventprise Llc |
Multivalent vlp conjugates
|
|
WO2017176796A1
(en)
|
2016-04-04 |
2017-10-12 |
University Of Virginia Patent Foundation |
Compositions and methods for preventing and treating disease
|
|
MA45052A
(fr)
|
2016-05-18 |
2019-03-27 |
Modernatx Inc |
Polynucléotides codant pour jagged1 pour le traitement du syndrome d'alagille
|
|
KR102906912B1
(ko)
|
2016-09-02 |
2026-01-05 |
사노피 파스퇴르 인크 |
네이세리아 메닌기티디스 백신
|
|
US11951165B2
(en)
|
2016-12-30 |
2024-04-09 |
Vaxcyte, Inc. |
Conjugated vaccine carrier proteins
|
|
ES3024474T3
(en)
|
2016-12-30 |
2025-06-04 |
Vaxcyte Inc |
Polypeptide-antigen conjugates with non-natural amino acids
|
|
AU2018215585B2
(en)
|
2017-01-31 |
2022-03-17 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
KR102101879B1
(ko)
*
|
2017-03-15 |
2020-05-29 |
주식회사 엘지화학 |
다가 폐렴구균 백신 조성물
|
|
AU2018243910B2
(en)
|
2017-03-28 |
2025-04-10 |
The Children's Medical Center Corporation |
A multiple antigen presenting system (MAPS)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof
|
|
WO2018213789A1
(en)
|
2017-05-18 |
2018-11-22 |
Modernatx, Inc. |
Modified messenger rna comprising functional rna elements
|
|
JP7285220B2
(ja)
|
2017-05-18 |
2023-06-01 |
モデルナティエックス インコーポレイテッド |
連結したインターロイキン－１２（ｉｌ１２）ポリペプチドをコードするポリヌクレオチドを含む脂質ナノ粒子
|
|
US10729763B2
(en)
|
2017-06-10 |
2020-08-04 |
Inventprise, Llc |
Mixtures of polysaccharide-protein pegylated compounds
|
|
MX2019014829A
(es)
|
2017-06-10 |
2020-08-17 |
Inventprise Llc |
Vacunas de conjugado multivalente con polisacáridos de conjugado bivalente o multivalente que proporcionan inmunogenicidad y avidez mejoradas.
|
|
EP3638292A1
(en)
|
2017-06-14 |
2020-04-22 |
ModernaTX, Inc. |
Polynucleotides encoding coagulation factor viii
|
|
WO2018237221A1
(en)
|
2017-06-23 |
2018-12-27 |
Nosocomial Vaccine Corporation |
IMMUNOGENIC COMPOSITIONS
|
|
US20220265856A1
(en)
|
2017-11-22 |
2022-08-25 |
Modernatx, Inc. |
Polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits for the treatment of propionic acidemia
|
|
JP7423521B2
(ja)
|
2017-11-22 |
2024-01-29 |
モダーナティエックス・インコーポレイテッド |
フェニルケトン尿症の治療用のフェニルアラニンヒドロキシラーゼをコードするポリヌクレオチド
|
|
EP3714048B1
(en)
|
2017-11-22 |
2025-04-09 |
ModernaTX, Inc. |
Polynucleotides encoding ornithine transcarbamylase for the treatment of urea cycle disorders
|
|
MA51523A
(fr)
|
2018-01-05 |
2020-11-11 |
Modernatx Inc |
Polynucléotides codant pour des anticorps anti-virus du chikungunya
|
|
KR102362777B1
(ko)
*
|
2018-03-27 |
2022-02-15 |
주식회사 녹십자 |
친화성 크로마토그래피 공정을 포함하는 백일해균 유래 단백질 수득 방법
|
|
WO2019226650A1
(en)
|
2018-05-23 |
2019-11-28 |
Modernatx, Inc. |
Delivery of dna
|
|
US11389519B2
(en)
|
2018-06-11 |
2022-07-19 |
Inventprise, Llc |
Virus-like particle conjugates
|
|
CN112543649B
(zh)
*
|
2018-07-04 |
2026-03-31 |
Vaxcyte公司 |
免疫原性缀合物的改进
|
|
US20220184185A1
(en)
|
2018-07-25 |
2022-06-16 |
Modernatx, Inc. |
Mrna based enzyme replacement therapy combined with a pharmacological chaperone for the treatment of lysosomal storage disorders
|
|
WO2020047201A1
(en)
|
2018-09-02 |
2020-03-05 |
Modernatx, Inc. |
Polynucleotides encoding very long-chain acyl-coa dehydrogenase for the treatment of very long-chain acyl-coa dehydrogenase deficiency
|
|
JP7535791B2
(ja)
|
2018-09-12 |
2024-08-19 |
ザ チルドレンズ メディカル センター コーポレーション |
肺炎球菌融合タンパク質ワクチン
|
|
IL281204B2
(en)
|
2018-09-12 |
2025-07-01 |
Affinivax Inc |
Multivalent pneumococcal vaccines
|
|
WO2020056147A2
(en)
|
2018-09-13 |
2020-03-19 |
Modernatx, Inc. |
Polynucleotides encoding glucose-6-phosphatase for the treatment of glycogen storage disease
|
|
US20220243182A1
(en)
|
2018-09-13 |
2022-08-04 |
Modernatx, Inc. |
Polynucleotides encoding branched-chain alpha-ketoacid dehydrogenase complex e1-alpha, e1-beta, and e2 subunits for the treatment of maple syrup urine disease
|
|
WO2020056239A1
(en)
|
2018-09-14 |
2020-03-19 |
Modernatx, Inc. |
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
|
|
EP3856233A1
(en)
|
2018-09-27 |
2021-08-04 |
Modernatx, Inc. |
Polynucleotides encoding arginase 1 for the treatment of arginase deficiency
|
|
JP2022532078A
(ja)
|
2019-05-08 |
2022-07-13 |
アストラゼネカ アクチボラグ |
皮膚及び創傷のための組成物並びにその使用の方法
|
|
EP4034157A1
(en)
|
2019-09-27 |
2022-08-03 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
WO2021176409A1
(en)
*
|
2020-03-05 |
2021-09-10 |
Sanofi Healthcare India Private Limited |
Preservative combination for vaccine composition
|
|
US20230235298A1
(en)
|
2020-06-01 |
2023-07-27 |
Modernatx, Inc. |
Phenylalanine hydroxylase variants and uses thereof
|
|
WO2022035816A1
(en)
|
2020-08-10 |
2022-02-17 |
Inventprise, Llc |
Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24f
|
|
AU2021377895A1
(en)
|
2020-11-13 |
2023-06-15 |
Modernatx, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
US20240207444A1
(en)
|
2021-03-24 |
2024-06-27 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding phenylalanine hydroxylase and uses thereof
|
|
WO2022204370A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles and polynucleotides encoding ornithine transcarbamylase for the treatment of ornithine transcarbamylase deficiency
|
|
WO2022204371A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding glucose-6-phosphatase and uses thereof
|
|
US20240216288A1
(en)
|
2021-03-24 |
2024-07-04 |
Modernatx, Inc. |
Lipid nanoparticles containing polynucleotides encoding propionyl-coa carboxylase alpha and beta subunits and uses thereof
|
|
WO2022204369A1
(en)
|
2021-03-24 |
2022-09-29 |
Modernatx, Inc. |
Polynucleotides encoding methylmalonyl-coa mutase for the treatment of methylmalonic acidemia
|
|
EP4355882A2
(en)
|
2021-06-15 |
2024-04-24 |
Modernatx, Inc. |
Engineered polynucleotides for cell-type or microenvironment-specific expression
|
|
WO2022271776A1
(en)
|
2021-06-22 |
2022-12-29 |
Modernatx, Inc. |
Polynucleotides encoding uridine diphosphate glycosyltransferase 1 family, polypeptide a1 for the treatment of crigler-najjar syndrome
|
|
IL326005A
(en)
|
2021-09-09 |
2026-03-01 |
Affinivax Inc |
Multivalent pneumococcal vaccines
|
|
US20250017867A1
(en)
|
2021-10-01 |
2025-01-16 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of fibrosis and/or cardiovascular disease
|
|
WO2023183909A2
(en)
|
2022-03-25 |
2023-09-28 |
Modernatx, Inc. |
Polynucleotides encoding fanconi anemia, complementation group proteins for the treatment of fanconi anemia
|
|
US20260035707A1
(en)
|
2022-07-26 |
2026-02-05 |
Modernatx, Inc. |
Engineered polynucleotides for temporal control of expression
|
|
WO2024197033A1
(en)
|
2023-03-21 |
2024-09-26 |
Modernatx, Inc. |
Polynucleotides encoding relaxin for the treatment of heart failure
|
|
CN118831156A
(zh)
*
|
2023-04-23 |
2024-10-25 |
康希诺生物股份公司 |
一种联合疫苗及其制备方法和应用
|
|
EP4704816A1
(en)
|
2023-05-03 |
2026-03-11 |
ModernaTX, Inc. |
Polynucleotides encoding cystic fibrosis transmembrane conductance regulator for the treatment of cystic fibrosis
|
|
WO2025072482A1
(en)
|
2023-09-27 |
2025-04-03 |
Modernatx, Inc. |
Immunoglobulin a protease polypeptides, polynucleotides, and uses thereof
|
|
WO2025255199A1
(en)
|
2024-06-05 |
2025-12-11 |
Modernatx, Inc. |
Argininosuccinate synthase 1 and argininosuccinate lyase polypeptides and polynucleotides and uses thereof
|